RNA-guided retargeting of Sleeping Beauty transposition in human cells

  1. Adrian Kovač
  2. Csaba Miskey
  3. Michael Menzel
  4. Esther Grueso
  5. Andreas Gogol-Döring
  6. Zoltan Ivics  Is a corresponding author
  1. Paul Ehrlich Institute, Germany
  2. University of Applied Sciences, Germany

Abstract

An ideal tool for gene therapy would enable efficient gene integration at predetermined sites in the human genome. Here we demonstrate biased genome-wide integration of the Sleeping Beauty (SB) transposon by combining it with components of the CRISPR/Cas9 system. We provide proof-of-concept that it is possible to influence the target site selection of SB by fusing it to a catalytically inactive Cas9 (dCas9) and by providing a single guide RNA (sgRNA) against the human Alu retrotransposon. Enrichment of transposon integrations was dependent on the sgRNA, and occurred in an asymmetric pattern with a bias towards sites in a relatively narrow, 300-bp window downstream of the sgRNA targets. Our data indicate that the targeting mechanism specified by CRISPR/Cas9 forces integration into genomic regions that are otherwise poor targets for SB transposition. Future modifications of this technology may allow the development of methods for specific gene insertion for precision genetic engineering.

Data availability

DNA sequence data generated and analysed during this study are included in the manuscript and Source Data Files 1-4.

Article and author information

Author details

  1. Adrian Kovač

    Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany
    Competing interests
    No competing interests declared.
  2. Csaba Miskey

    Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany
    Competing interests
    No competing interests declared.
  3. Michael Menzel

    Bioinformatics, University of Applied Sciences, Giessen, Germany
    Competing interests
    No competing interests declared.
  4. Esther Grueso

    Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany
    Competing interests
    No competing interests declared.
  5. Andreas Gogol-Döring

    Bioinformatics, University of Applied Sciences, Giessen, Germany
    Competing interests
    No competing interests declared.
  6. Zoltan Ivics

    Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany
    For correspondence
    zoltan.ivics@pei.de
    Competing interests
    Zoltan Ivics, Patent applications around targeted transposon integration technology(Patent Nos. EP1594971B1, EP1594972B1 and EP1594973B1)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7803-6658

Funding

No external funding was received for this work.

Copyright

© 2020, Kovač et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,187
    views
  • 1,111
    downloads
  • 42
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Adrian Kovač
  2. Csaba Miskey
  3. Michael Menzel
  4. Esther Grueso
  5. Andreas Gogol-Döring
  6. Zoltan Ivics
(2020)
RNA-guided retargeting of Sleeping Beauty transposition in human cells
eLife 9:e53868.
https://doi.org/10.7554/eLife.53868

Share this article

https://doi.org/10.7554/eLife.53868

Further reading

    1. Biochemistry and Chemical Biology
    Luca Unione, Jesús Jiménez-Barbero
    Insight

    Glycans play an important role in modulating the interactions between natural killer cells and antibodies to fight pathogens and harmful cells.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Kristina Ehring, Sophia Friederike Ehlers ... Kay Grobe
    Research Article

    The Sonic hedgehog (Shh) signaling pathway controls embryonic development and tissue homeostasis after birth. This requires regulated solubilization of dual-lipidated, firmly plasma membrane-associated Shh precursors from producing cells. Although it is firmly established that the resistance-nodulation-division transporter Dispatched (Disp) drives this process, it is less clear how lipidated Shh solubilization from the plasma membrane is achieved. We have previously shown that Disp promotes proteolytic solubilization of Shh from its lipidated terminal peptide anchors. This process, termed shedding, converts tightly membrane-associated hydrophobic Shh precursors into delipidated soluble proteins. We show here that Disp-mediated Shh shedding is modulated by a serum factor that we identify as high-density lipoprotein (HDL). In addition to serving as a soluble sink for free membrane cholesterol, HDLs also accept the cholesterol-modified Shh peptide from Disp. The cholesteroylated Shh peptide is necessary and sufficient for Disp-mediated transfer because artificially cholesteroylated mCherry associates with HDL in a Disp-dependent manner, whereas an N-palmitoylated Shh variant lacking C-cholesterol does not. Disp-mediated Shh transfer to HDL is completed by proteolytic processing of the palmitoylated N-terminal membrane anchor. In contrast to dual-processed soluble Shh with moderate bioactivity, HDL-associated N-processed Shh is highly bioactive. We propose that the purpose of generating different soluble forms of Shh from the dual-lipidated precursor is to tune cellular responses in a tissue-type and time-specific manner.